GENEDX HOLDINGS (WGS)
(Delayed Data from NSDQ)
$28.00 USD
+0.24 (0.86%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $28.04 +0.04 (0.14%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth B Momentum C VGM
Cash flow Statements
Fiscal Year End for GeneDx Holdings Corp falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -175.77 | -548.98 | -245.39 | -0.19 | -29.70 |
Depreciation/Amortization & Depletion | 33.73 | 59.83 | 21.87 | 0.00 | 6.41 |
Net Change from Assets/Liabilities | -38.24 | 33.88 | 8.08 | -0.18 | -0.74 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 0.13 | 136.12 | 25.00 | 1.20 | 5.31 |
Net Cash From Operating Activities | -180.15 | -319.16 | -190.43 | -0.39 | -18.73 |
Property & Equipment | -1.68 | -14.32 | -20.79 | 0.00 | -15.46 |
Acquisition/ Disposition of Subsidiaries | -12.14 | -127.00 | 0.00 | 0.00 | 0.00 |
Investments | -29.91 | 0.00 | 0.00 | -442.75 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -43.73 | -141.33 | -20.79 | -442.75 | -15.46 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 143.29 | 200.61 | 559.50 | 444.75 | 118.82 |
Issuance (Repayment) of Debt | 42.95 | -3.29 | -13.47 | -0.05 | -1.71 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | -52.30 | -0.47 | 30.90 |
Net Cash from Financing Activities | 186.24 | 197.32 | 493.73 | 444.23 | 148.01 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -37.64 | -263.17 | 282.51 | 1.09 | 113.83 |
Cash at Beginning of Period | 138.30 | 401.47 | 118.96 | 0.00 | 1.18 |
Cash at End of Period | 100.67 | 138.30 | 401.47 | 1.09 | 115.01 |
Diluted Net EPS | -7.23 | -53.80 | -74.92 | -0.66 | NA |
Fiscal Year End for GeneDx Holdings Corp falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -20.24 | -175.77 | -149.99 | -107.71 | -60.99 |
Depreciation/Amortization & Depletion | 5.25 | 33.73 | 28.03 | 19.23 | 8.76 |
Net Change from Assets/Liabilities | -7.68 | -38.24 | -29.88 | -15.18 | -6.21 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 6.26 | 0.13 | 1.55 | -5.40 | 2.87 |
Net Cash From Operating Activities | -16.41 | -180.15 | -150.29 | -109.06 | -55.56 |
Property & Equipment | -0.44 | -1.68 | 0.55 | 0.41 | -0.46 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -12.14 | -12.14 | -12.14 | 0.00 |
Investments | 1.29 | -29.91 | -27.27 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.84 | -43.73 | -38.86 | -11.73 | -0.46 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.02 | 143.29 | 0.27 | 0.27 | 135.71 |
Issuance (Repayment) of Debt | -0.46 | 42.95 | -4.13 | -3.22 | -3.05 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 143.00 | 143.00 | 0.00 |
Net Cash from Financing Activities | -0.44 | 186.24 | 139.14 | 140.05 | 132.66 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -16.01 | -37.64 | -50.02 | 19.25 | 76.64 |
Cash at Beginning of Period | 100.67 | 138.30 | 138.30 | 138.30 | 138.30 |
Cash at End of Period | 84.66 | 100.67 | 88.29 | 157.56 | 214.94 |
Diluted Net EPS | -0.78 | -0.71 | -1.64 | -1.84 | -3.04 |